— Okta shares surged 12.4% after the access management company topped analysts' second-quarter earnings expectation and issued a strong full-year outlook. The company reported adjusted earnings of 31 cents per share, excluding items, on revenues totaling $556 million.
That came in ahead of the earnings per share of 22 cents and $535 million in revenue expected by analysts polled by Refinitiv.— The discount retail stock slumped 4.8% on disappointing third-quarter guidance. For the current period, Five Below said it expects revenues to range between $715 million and $730 million, versus the $738 million expected by analysts polled by StreetAccount. Earnings per share estimates also came in below expectations.
این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:
ایران آخرین اخبار, ایران سرفصلها
Similar News:همچنین می توانید اخبار مشابهی را که از منابع خبری دیگر جمع آوری کرده ایم، بخوانید.
Stocks making the biggest moves after hours: Salesforce, Okta, CrowdStrike, Five Below and moreThese are the stocks posting the largest moves in extended trading.
منبع: NBCNewYork - 🏆 270. / 63 ادامه مطلب »
These Stocks Are Moving the Most Today: Salesforce, Okta, UBS, CrowdStrike, Chewy, and MoreSalesforce issues an outlook for the third quarter and fiscal year better than analysts' forecasts, Okta raises its fiscal-year outlook, and UBS reports a...
منبع: MarketWatch - 🏆 3. / 97 ادامه مطلب »
These Stocks Are Moving the Most Today: Salesforce, Okta, UBS, Chewy, Palantir, CrowdStrike, and MoreSalesforce issues an outlook for the third quarter and fiscal year better than analysts' forecasts, Okta raises its fiscal-year outlook, and UBS reports a...
منبع: MarketWatch - 🏆 3. / 97 ادامه مطلب »
Stocks making the biggest premarket moves: Dollar General, Salesforce, Palantir and moreThese are the stocks posting the largest moves in the premarket.
منبع: NBCPhiladelphia - 🏆 569. / 51 ادامه مطلب »
Tilray and Curaleaf Stocks Surge as DEA Considers Reclassifying MarijuanaThe Drug Enforcement Agency said it is considering reclassifying weed as a Schedule 3 drug, rather than as a Schedule 1 substance.
منبع: MarketWatch - 🏆 3. / 97 ادامه مطلب »